A Senate bill to mandate lot-level track-and-trace for pharmaceuticals could go over cost limits for the private sector, according to a report from the Congressional Budget Office. The measure is expected to put a strain on pharmaceutical companies, which will need to pay fees, maintain transaction records for six years and verify transaction information.
Wholesalers and third-party logistics providers for drug companies likely will pay about $35 million in fees, CBO estimates.

Full Story:
Securing Industry

Related Summaries